Xarelto Lawsuit Plaintiffs Question Lack of Antidote

November 20, 2015 – – BloodThinnerHelp.com reports on lawsuits filed against Bayer AG and Janssen Pharmaceuticals (a division of pharmaceutical conglomerate Johnson & Johnson), which question blood-thinning drug Xarelto’s market release without corresponding antidote. The suits note that the lack of antidote, which is still the case today, is irresponsible and negligent. The drug, despite it’s lack of antidote, has been on the market for four years now, and has also become the subject of an increasing number of lawsuits which connect it to uncontrollable bleeding and death.

The lack of antidote means that when a patient who has Xarelto in their system is injured and starts to bleed, physicians are unable to reverse the drug’s effects to get that patient’s blood to clot. This can put the patient at serious risk for uncontrollable bleeding. In these cases, doctors resort to life-saving measures such as blood transfusions in an attempt to save the patient’s life.

Traditional blood thinners do not have this problem. Their effects can be countered by vitamin K. When patients who use traditional blood thinners such as warfarin are injured and bleeding, physicians administer vitamin K, and the patient’s blood will clot. This can be a truly life-saving difference, and is also the reason that many allege Xarelto to be the most dangerous blood thinner currently on the market.

Anyone who has used Xarelto and who has suffered adverse health effects that they attribute to the drug may be able to file a lawsuit and may be entitled to compensation for their damages. At this time, Federal Xarelto lawsuits number over 1,700, and mass tort cases in Philadelphia have risen to over 400 cases. Together, over 2,000 plaintiffs have stepped up to sue for damages they believe to be associated with the anticoagulant. Those involved in the litigation expect additional cases to be filed as those in the MDL await trial.

As these cases continue to mount, Attorney Marc Goldich is working to help anyone involved. He offers free legal consultations for prior Xarelto patients who have suffered health issues they attribute to the drug.

For more information on Xarelto uncontrollable bleeding lawsuits, or to ask questions, contact Marc Goldich, Esq. by calling 866-425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60005660